Recombinant Glycoprotein Vaccines for Human Immunodeficiency Virus-Infected Children and Their Effects on Viral Quasispecies
In individuals infected with human immunodeficiency virus type 1 (HIV-1), specific immunity is associated with a more diverse viral repertoire and slower disease progression. Attempts to enhance antiviral immunity with therapeutic vaccination have shown that recombinant glycoprotein (RGP) vaccines a...
Kaydedildi:
| Yayımlandı: | Clin Diagn Lab Immunol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
2002
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC119877/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11777833/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/CDLI.9.1.79-82.2002 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
